Background:
Child-onset asthma is known to remit with high probability, but remission in adult-onset asthma is seemingly less frequent. Reports of the association between remission and asthma age of onset up to late adulthood are scarce.
Objective:
To evaluate the association between asthma remission, age at diagnosis and gender, and assess risk factors of nonremission.
Methods:
In 2016, a random sample of 16,000 subjects aged 20 to 69 years from Helsinki and Western Finland were sent a FinEsS questionnaire. Physician-diagnosed asthma was categorized by age at diagnosis to early- (0-11 years), intermediate- (12-39 years), and late-diagnosed (40-69 years) asthma. Asthma remission was defined by not having had asthma symptoms and not having used asthma medication in the past 12 months.
Results:
Totally, 8199 (51.5%) responded, and 879 reported physician-diagnosed asthma. Remission was most common in early-diagnosed (30.2%), followed by intermediate-diagnosed (17.9%), and least common in late-diagnosed asthma (5.0%) (P < .001), and the median times from diagnosis were 27, 18.5, and 10 years, respectively. In males, the corresponding remission rates were 36.7%, 20.0%, and 3.4%, and in females, 20.4%, 16.6%, and 5.9% (gender difference P < .001). In multivariable binary logistic regression analysis, significant risk factors of asthma nonremission were intermediate (odds ratio [OR] = 2.15, 95% confidence interval: 1.37-3.36) and late diagnosis (OR = 11.06, 4.82-25.37) compared with early diagnosis, chronic obstructive pulmonary disease (COPD) (OR = 5.56, 1.26-24.49), allergic rhinitis (OR = 2.28, 1.50-3.46), and family history of asthma (OR = 1.86, 1.22-2.85). Results were similar after excluding COPD.
Conclusion:
Remission was rare in adults diagnosed with asthma after age 40 years in both genders. Late-diagnosed asthma was the most significant independent risk factor for nonremission.
Citing Articles
Documentation of comorbidities, lifestyle factors, and asthma management during primary care scheduled asthma contacts.
Takala J, Vahatalo I, Tuomisto L, Niemela O, Ilmarinen P, Kankaanranta H
NPJ Prim Care Respir Med. 2024; 34(1):2.
PMID: 38461294
PMC: 10925028.
DOI: 10.1038/s41533-024-00360-3.
Relationship between early life asthma and chronic airway disease in adult life - in search for disease trajectories over the life span- the RELATE study based on the Kongsberg cohort.
Savran O, Bonnelykke K, Ulrik C
BMC Pulm Med. 2023; 23(1):363.
PMID: 37770870
PMC: 10540471.
DOI: 10.1186/s12890-023-02661-8.
Exogenous female sex steroid hormones and new-onset asthma in women: a matched case-control study.
Zhang G, Basna R, Mathur M, Lasser C, Mincheva R, Ekerljung L
BMC Med. 2023; 21(1):337.
PMID: 37667254
PMC: 10478448.
DOI: 10.1186/s12916-023-03038-8.
Allergic sensitisation and type-2 inflammation is associated with new-onset and persistent allergic disease.
Blondal V, Sundbom F, Zhou X, Moverare R, Borres M, Hogman M
Clin Transl Allergy. 2023; 13(4):e12240.
PMID: 37186426
PMC: 10080081.
DOI: 10.1002/clt2.12240.
Validation of Diagnostic Coding for Asthma in an Electronic Health Record System in Hong Kong.
Kwok W, Tam T, Sing C, Chan E, Cheung C
J Asthma Allergy. 2023; 16:315-321.
PMID: 37006594
PMC: 10065416.
DOI: 10.2147/JAA.S405297.
Characteristics of inpatients with atopic asthma in a tertiary center: do age and gender have an influence?.
Al-Iede M, Aleidi S, Al Oweidat K, Dannoun M, Alsmady D, Faris H
Multidiscip Respir Med. 2022; 17:883.
PMID: 36466722
PMC: 9714292.
DOI: 10.4081/mrm.2022.883.
Clinical Remission of Asthma and Allergic Rhinitis - in a Longitudinal Population Study.
Heldin J, Malinovschi A, Johannessen A, Alving K, Holm M, Franklin K
J Asthma Allergy. 2022; 15:1569-1578.
PMID: 36387839
PMC: 9643071.
DOI: 10.2147/JAA.S378584.
Impacts of COVID-19 Prevention and Control Measures on Asthma-Related Hospital and Outpatient Visits in Yichang, China.
Wang J, Yin D, Li G, Wang T, Zhang Y, Gan H
Int J Environ Res Public Health. 2022; 19(20).
PMID: 36294152
PMC: 9603737.
DOI: 10.3390/ijerph192013572.
Age at asthma diagnosis is related to prevalence and characteristics of asthma symptoms.
Hisinger-Molkanen H, Honkamaki J, Kankaanranta H, Tuomisto L, Backman H, Andersen H
World Allergy Organ J. 2022; 15(9):100675.
PMID: 36185544
PMC: 9489807.
DOI: 10.1016/j.waojou.2022.100675.
Correlation of Activation Site and Number with the Clinical Response to Bronchial Thermoplasty.
Wang T, Long F, Huang Z, Long L, Huang W, Hu S
J Asthma Allergy. 2022; 15:437-452.
PMID: 35418759
PMC: 9000564.
DOI: 10.2147/JAA.S357037.
Sex Disparities in Asthma Development and Clinical Outcomes: Implications for Treatment Strategies.
Zhang G, Ozuygur Ermis S, Radinger M, Bossios A, Kankaanranta H, Nwaru B
J Asthma Allergy. 2022; 15:231-247.
PMID: 35210789
PMC: 8863331.
DOI: 10.2147/JAA.S282667.
Participation in scheduled asthma follow-up contacts and adherence to treatment during 12-year follow-up in patients with adult-onset asthma.
Takala J, Vahatalo I, Tuomisto L, Niemela O, Ilmarinen P, Kankaanranta H
BMC Pulm Med. 2022; 22(1):63.
PMID: 35168565
PMC: 8845345.
DOI: 10.1186/s12890-022-01850-1.
Proximity to Heavy Traffic Roads and Patient Characteristics of Late of Onset Asthma in an Urban Asthma Center.
Lin T, Lin H, Liu Y, Lo Y, Wang C, Chang P
Front Med (Lausanne). 2022; 8:783720.
PMID: 34977086
PMC: 8716741.
DOI: 10.3389/fmed.2021.783720.
Natural history and associated early life factors of childhood asthma: a population registry-based cohort study in Denmark.
Chen Q, Chen J, Zhou Y, Huang L, Tang Y, Li J
BMJ Open. 2021; 11(11):e045728.
PMID: 34824103
PMC: 8627404.
DOI: 10.1136/bmjopen-2020-045728.
Influence of Childhood Exposure to a Farming Environment on Age at Asthma Diagnosis in a Population-Based Study.
Andersen H, Ilmarinen P, Honkamaki J, Tuomisto L, Hisinger-Molkanen H, Backman H
J Asthma Allergy. 2021; 14:1081-1091.
PMID: 34522104
PMC: 8434911.
DOI: 10.2147/JAA.S323504.